APA (7th ed.) Citation

Chun-Huei Liao, Chih-Ching Yen, Hsiao-Ling Chen, Yu-Hsien Liu, Yu-Hsuan Chen, Ying-Wei Lan, . . . Chuan-Mu Chen. (2023). Novel Kefir Exopolysaccharides (KEPS) Mitigate Lipopolysaccharide (LPS)-Induced Systemic Inflammation in Luciferase Transgenic Mice through Inhibition of the NF-κB Pathway. MDPI AG.

Chicago Style (17th ed.) Citation

Chun-Huei Liao, Chih-Ching Yen, Hsiao-Ling Chen, Yu-Hsien Liu, Yu-Hsuan Chen, Ying-Wei Lan, Ke-Rong Chen, Wei Chen, and Chuan-Mu Chen. Novel Kefir Exopolysaccharides (KEPS) Mitigate Lipopolysaccharide (LPS)-Induced Systemic Inflammation in Luciferase Transgenic Mice Through Inhibition of the NF-κB Pathway. MDPI AG, 2023.

MLA (9th ed.) Citation

Chun-Huei Liao, et al. Novel Kefir Exopolysaccharides (KEPS) Mitigate Lipopolysaccharide (LPS)-Induced Systemic Inflammation in Luciferase Transgenic Mice Through Inhibition of the NF-κB Pathway. MDPI AG, 2023.